2 Reasons AFRM is Risky and 1 Stock to Buy Instead

AFRM Cover Image

Affirm’s stock price has taken a beating over the past six months, shedding 50.4% of its value and falling to $44.70 per share. This might have investors contemplating their next move.

Is there a buying opportunity in Affirm, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Is Affirm Not Exciting?

Even though the stock has become cheaper, we don't have much confidence in Affirm. Here are two reasons why AFRM doesn't excite us and a stock we'd rather own.

1. Previous Growth Initiatives Have Lost Money

Return on equity, or ROE, quantifies bank profitability relative to shareholder equity - an essential capital source for these institutions. Over extended periods, superior ROE performance drives faster shareholder wealth compounding through reinvestment, share repurchases, and dividend growth.

Over the last five years, Affirm has averaged an ROE of negative 20.2%, a bad result not only in absolute terms but also relative to the majority of firms putting up 25%+. It also shows that Affirm has little to no competitive moat.

Affirm Return on Equity

2. High Debt Levels Increase Risk

Affirm reported $2.25 billion of cash and $9.14 billion of debt on its balance sheet in the most recent quarter.

As investors in high-quality companies, we primarily focus on whether a company’s profits can support its debt.

Affirm Net Debt Position

With $1.04 billion of EBITDA over the last 12 months, we view Affirm’s 6.6× net-debt-to-EBITDA ratio as inadequate. The company’s lacking profits relative to its borrowings give it little breathing room, raising red flags.

Final Judgment

Affirm isn’t a terrible business, but it doesn’t pass our quality test. Following the recent decline, the stock trades at 12× forward P/E (or $44.70 per share). While this valuation is reasonable, we don’t really see a big opportunity at the moment. We're pretty confident there are more exciting stocks to buy at the moment. We’d recommend looking at one of our all-time favorite software stocks.

Stocks We Would Buy Instead of Affirm

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.37
-3.39 (-1.62%)
AAPL  247.99
-0.97 (-0.39%)
AMD  201.33
-3.94 (-1.92%)
BAC  47.16
+0.15 (0.32%)
GOOG  298.79
-6.94 (-2.27%)
META  593.66
-13.04 (-2.15%)
MSFT  381.87
-7.15 (-1.84%)
NVDA  172.70
-5.86 (-3.28%)
ORCL  149.68
-5.84 (-3.76%)
TSLA  367.96
-12.34 (-3.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.